tradmap

MRSH Financials Marsh McLennan

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 9.2% per year over the past 5 years.
  • Net income has grown faster than revenue (15.6% vs 9.2% per year).
  • Free cash flow has grown 10.5% per year over the past 5 years.

Financial health

  • Total debt ($19.6B) exceeds cash ($2.7B); net debt is $16.9B.
  • Total debt has grown in line with revenue (10.6% vs 9.2% per year).
  • Operating income covered interest expense 6.5× in the latest year.
  • Total debt is 3.0× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 40.8% of earnings and 34.0% of free cash flow.
  • The dividend has grown 12.5% per year over the past 5 years.
Revenue & net income
$0 $13B $27B 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 12% 24% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
0% 15% 30% 2011 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
$0 $3B $5B 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $10B $20B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$9B -$2B $5B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $27.0B $4.2B 0.0% 23.1% 27.2% 7.1% $5.0B $19.6B $2.7B
2024 $24.5B $4.1B 0.0% 23.8% 30.0% 7.2% $4.0B $19.9B $2.4B
2023 $22.7B $3.8B 0.0% 23.2% 30.4% 7.8% $3.8B $13.5B $3.4B
2022 $20.7B $3.0B 0.0% 20.7% 28.4% 6.9% $3.0B $11.8B $1.4B
2021 $3.1B 28.0% 7.1% $3.1B $11.0B $1.8B
2020 $2.0B 21.8% 6.1% $3.0B $11.8B $2.1B
2019 $1.7B 21.9% 5.6% $1.9B $13.2B $1.2B
2018 $1.6B 21.8% 7.6% $2.1B $6.1B $1.1B
2017 $1.5B 20.0% 7.3% $1.6B $1.2B
2016 $1.8B 28.2% 9.7% $1.8B $1.0B
2015 $1.6B 24.2% 8.8% $1.6B $1.4B
2014 $1.5B 20.5% 8.2% $1.8B $3.4B $2.0B
2013 $1.4B 17.0% 8.0% $940M $2.3B
2012 $1.2B 17.8% 7.2% $1.0B $2.3B
2011 $993M 16.7% 6.4% $1.4B $2.1B

Valuation over time

How the market has priced MRSH against its own fundamentals since 2026-01 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 10.9 21.8 Jan '26 Feb '26 Mar '26 Apr '26 May '26 Jun '26 Jul '26 Aug '26 Sep '26
P/E
Price / sales (P/S)
0.0 1.7 3.4 Jan '26 Feb '26 Mar '26 Apr '26 May '26 Jun '26 Jul '26 Aug '26 Sep '26
P/S
Dividend yield (%)
0.0 1.1 2.2 Jan '26 Feb '26 Mar '26 Apr '26 May '26 Jun '26 Jul '26 Aug '26 Sep '26
Dividend yield %

Frequently asked questions

Is MRSH growing its revenue and profit?

Over the past 5 years, Marsh McLennan's revenue has grown 9.2% per year, and net income grown 15.6% per year. These are computed facts, not advice.

How much debt does MRSH have?

As of FY2025, Marsh McLennan reported $19.6B of total debt against $2.7B of cash; operating income covered interest expense 6.5×.

What is MRSH's profit margin?

In FY2025, gross margin was —, operating margin 23.1%, and net margin 15.4%.

What is MRSH's P/E ratio?

As of Sep '26, Marsh McLennan traded at a price-to-earnings ratio of about 21.6× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.